PFASter - Final Report

PFASter focused on the creation of a lateral flow assay (LFA) designed to detect the presence of PFAS substances in surface waters. LFAs are already well-established in medical diagnostics (e.g., pregnancy tests and COVID-19 antigen tests) and offer advantages such as ease of use, rapid results, affordability, and minimal equipment requirements.

Over the course of the PFASter project, significant progress was made in developing aptamer-based detection strategies for PFAS, despite the challenges posed by this class of small-molecule targets. These strategies revealed consistent and unexpected behavior: unmodified ssDNA aptamers displayed interactions with PFAS compounds that were often non-sequence-specific, suggesting that electrostatic or hydrophobic forces may drive binding rather than canonical aptamer-target affinity. While development of an LFA prototype was achieved and multiple technical obstacles were overcome, such as nanoparticle aggregation, test line clogging, and irreproducible signal generation, the capture-probes’ (aptamers) weak target-induced responses ultimately limited the success of the platform in its current form.

While the PFASter project did not yield a commercially deployable detection platform, it resulted in substantial knowledge generation and methodological advancements. These outcomes provide a valuable foundation for future development and broader application of aptamer-based technologies in environmental monitoring.

Read the MUDP-report.